MedTrace Logo

MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis

NCT01368913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2013-06-12

No results posted yet for this study

Summary

Desmopressin in treatment of nocturnal enuresis (bedwetting).

Conditions

  • Nocturnal Enuresis

Sponsors & Collaborators

  • Ferring Arzneimittel GmbH

    collaborator INDUSTRY

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01368913 on ClinicalTrials.gov